ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tulic, M.
Right arrow Articles by Sly, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tulic, M.
Right arrow Articles by Sly, P.
Eur Respir J 2000; 15: 870-877
Copyright © ERS Journals Ltd 2000

Original Articles

Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model

MK Tulic, JL Wale, PG Holt, and PD Sly

The in vivo role of nitric oxide in inflammatory cell migration, vascular permeability and the development of hyperresponsiveness to methacholine (MCh) was studied in rats 24 h following ovalbumin (OVA) challenge. The NO synthase (NOS) inhibitors N(G)-mono-methyl-L-arginine (L-NMMA; nonselective), aminoguanidine (two-fold inducible NOS-selective), N(omega)-nitro-L-arginine methyl ester (L-NAME; 2000-fold endothelial cell NOS-selective) or S-methyl-L-thiocitrulline (100-fold neuronal NOS-selective) were administered (100 mg x kg(-1) s.c.) to OVA-sensitized Piebald-Virol-Glaxo rats on 3 consecutive days during which they were challenged with allergen (1% OVA). Responses to inhaled MCh were measured in anaesthetized animals 24 h after OVA challenge. Cellular inflammation and vascular permeability were assessed using bronchoalveolar lavage (BAL) fluid collected 30 min after administration of Evans blue (50 mg x kg(-1) i.v.). OVA challenge in sensitized animals induced hyperresponsiveness to MCh, inflammatory cell influx and increased leakage of Evans blue into the BAL fluid (n=9, p<0.001). Aminoguanidine was effective in inhibiting the allergen-induced cellular influx and microvascular leakage (n=9, p<0.001) without altering responses to MCh. This effect was reserved by L-arginine. L-NAME (n=5, p<0.01) and S-methyl-L-thiocitrulline (n=6, p<0.001) further potentiated the allergen-induced hyperresponsiveness without altering cellular inflammation. L-NMMA attenuated both the OVA-induced cellular influx and Evans blue leakage (n=8, p<0.001) as well as further potentiating the hyperresponsiveness to MCh (p<0.05). From these studies, it is suggested that, in allergic Piebald-Virol-Glaxo rats, nitric oxide production by inducible nitric oxide synthase plays a role in the migration of inflammatory cells and increase in vascular permeability following allergen challenge, whereas nitric oxide produced by the constitutively expressed neuronal nitric oxide synthase limits hyperresponsiveness to methacholine.


This article has been cited by other articles:


Home page
 ChestHome page
C. Brindicci, K. Ito, P. J. Barnes, and S. A. Kharitonov
Effect of an Inducible Nitric Oxide Synthase Inhibitor on Differential Flow-Exhaled Nitric Oxide in Asthmatic Patients and Healthy Volunteers
Chest, August 1, 2007; 132(2): 581 - 588.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. R. Hodges, M. A. Shatos, R. S. Tarko, J. Vrouvlianis, J. Gu, and D. A. Dartt
Nitric Oxide and cGMP Mediate {alpha}1D-Adrenergic Receptor-Stimulated Protein Secretion and p42/p44 MAPK Activation in Rat Lacrimal Gland
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2781 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C Lane, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, and S Stick
Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath
Thorax, September 1, 2004; 59(9): 757 - 760.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P J Franklin, S W Turner, P N Le Souef, and S M Stick
Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children
Thorax, December 1, 2003; 58(12): 1048 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. R. Eynott, N. Paavolainen, D. A. Groneberg, A. Noble, M. Salmon, P. Nath, S.-Y. Leung, and K. F. Chung
Role of Nitric Oxide in Chronic Allergen-Induced Airway Cell Proliferation and Inflammation
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
N. L. Harris, V. Watt, F. Ronchese, and G. Le Gros
Differential T Cell Function and Fate in Lymph Node and Nonlymphoid Tissues
J. Exp. Med., February 4, 2002; 195(3): 317 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. M. Stick
Exhaled Nitric Oxide in Difficult Childhood Asthma . More Light or Still Chasing Shadows?
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1335 - 1336.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. A. Knight, P. G. Holt, and P. D. Sly
Lipopolysaccharide Inhibits the Late-Phase Response to Allergen by Altering Nitric Oxide Synthase Activity and Interleukin-10
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 640 - 646.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.